It is often said that Marie Skłodowska-Curie died of "aplastic anemia." Try Googling it; you'll find many hits. But I am not so sure. She died on July 4th, 1934, at a sanatorium called Sancellemoz, in Passy, Haute-Savoie, France, after a long illness. #aplasticanemia#MDS /1
The 1937 biography by her younger daughter Ève describes her final illness, including a consultation at Sancellemoz (postcard) by a "Professor Roch." That would have been Maurice Roch, Regent of @UNIGEnews & father of famous Alpinist André Roch who planned Aspen, Colorado./3
Here is how the daughter's biography describes that consultation. Mention is made of fevers and blood tests - rapidly falling WBC & RBC counts - and that X-rays were done. (The last thing she needed: more radiation!). Diagnosis: "Pernicious anaemia in its extreme form." /3
It is unclear if Mme. Sklodowska-Curie underwent a marrow biopsy. The @nytimes ran her obituary the following day, and stated her cause of death as "a form of pernicious anaemia". (Interesting to see @Wimbledon 🎾 scores next to the obituary - it was July 4th week after all.)/4
Aplastic anemia was well recognized by 1934. It had first been described in 1888 at autopsy in a 21 year-old pregnant woman named Hedwig S. with “strikingly hypocellular” marrow - by Paul Ehrlich at Charite in Berlin, in this case report./5
The term "aplastic anemia" is usually said to have been coined in 1904 by this guy: Anatole Chauffard in Paris. The key paper was "Un cas d’anémie pernicieuse aplastique" in the Bulletin Soc Med Hop Paris, 21 (1904): 303f. But... notice the "pernicious" in the paper's title./6
Richard Clarke Cabot in Boston (depicted - he started the clinicopathological case series in @NEJM) summarized 24 cases of aplastic anemia the 1908 version of text, emphasizing hypocellularity. If Mme Curie had #aplasticanemia we might have expected Roch to give that diagnosis./6
(BTW: back then people reported *original* research in textbooks! Osler's 1892 first edition of his Principles and Practice text is packed with his own unpublished observations. Now, of course, textbooks are so long in gestation that anyone who tried that would get 'scooped'.)/7
In contrast to aplastic anemia, myelodysplastic syndromes were not yet well described in 1934. "Refractory anemia" term dates to a 1938 paper by the notorious C.P. "Dusty" Rhoads. I summarized some of that history in a 2012 Leukemia Research paper./8 sciencedirect.com/science/articl…
Since pernicious anemia is associated with blood/marrow cell dysmorphology, as in these 2 @ASH_hematology image bank photomicrographs, and the megaloblastic changes in pernicious anemia overlap with findings in #MDS, many early MDS cases were mistaken for pernicious anemia./9
Aplastic anemia induced by ionizing radiation is often (albeit not always) the result of a single large myeloablative dose. Therapy- or exposure-related MDS, in contrast, has a different epidemiology and may result from lower dose chronic exposure./10 ashpublications.org/hematology/art…
Mme. Curie died at age 66 & had many years of lower-dose exposures to various radioisotopes./11 history.aip.org/exhibits/curie…
Already in 1920 the health effects of radium in particular were well recognized. Mme. Curie wrote to her sister Bronya in 1920, "“Perhaps radium has something to do with these troubles, but it cannot be affirmed with certainty.” "Radium Girl" lawsuits began in the 1920s./12
So while it is not impossible for Marie Skłodowska-Curie to have died of aplastic anemia, as the Nobel Foundation tweeted yesterday, MDS, or another chronic myeloid neoplasm (MF is unlikely given lack of mention of a spleen), or even actue leukemia are more likely. /End
• • •
Missing some Tweet in this thread? You can try to
force a refresh
Did you ever wonder why our marrow is located inside of our *bones*, #MedTwitter? There’s no a priori anatomical reason it should be sited there. Blood cells could form in our spleens & livers, as they do during our fetal lives; or elsewhere, as in some animals. Let’s discuss! /1
After all, zebrafish get along just fine making blood cells in their “kidney marrow”, keeping @leonard_zon's lab running. Drosophila make blood-like cells in abdominal hubs, and frogs… frogs mix it up. Jeremiah Bullfrog & frog cousins make blood in kidneys, marrow, liver, etc./2
Hematopoietic stem cells (HSCs) are like seafarers or long-haul truckers: they have a tough, unforgiving job requiring long hours. They must generate >2×10¹¹ blood cells daily, over the course of an organismal lifespan that might span >100 years. (HSC time image: @Goodell_Lab)/3
I was reviewing marrow failure history in preparation for an upcoming @aamdsif conference, and I’m completely awed by the observational skills of young physician Paul Strübing in Greifswald, Germany in 1882 describing the first clear case of paroxysmal nocturnal hemoglobinuria./1
This was the only photo I could find of Strübing, from over 20 years later (circa 1905). At the time of publication of his prescient 1882 paper, Strübing was 29 years old and had graduated from medical school 6 years earlier. /2
As William Crosby @TuftsMedSchool wrote in 1951 @BloodJournal, “Strübing’s paper on [PNH] might well be regarded as a classic of clinical investigation. He recognized clearly that the disease was a new entity and characterized it by a careful description of his patient."/3
Today marks the end of an era: publication of the final philatelic vignette (authors.elsevier.com/a/1g-uM5qq8Xpp3) co-authored by Robert Kyle @MayoClinic. Bob turned 95 this year and decided to step down from helping prepare these. He published his first vignette @JAMA_current back in 1969!/1
This longstanding series focused on medical & scientific-themed postage stamps began in 1961. At the 109th Annual Meeting of @AmerMedicalAssn in the then-new convention center in Miami Beach, Florida in June 1960, John Mirt (1897-1968) discussed “Medical Pathfinders on Stamps”./2
At the time, Mr. Mirt – a devoted Freemason - worked in press relations for the AMA in Chicago. After the meeting, he was asked by then-editor of @JAMA_current John Talbott (1902-1990) to start composing short articles about physicians & scientists featured on postage stamps./3
@OpenAI#ChatGPT4 "hallucinations" remind me of a now-amusing event from way back in Grade 3 when I was 7, involving the last time I knowingly confabulated. I was assigned to write a report about airplanes.✈️ One thing I already knew about airplanes: they were expensive! (1/12)
According to my parents, the high cost of airplane tickets was why our family always drove the tedious 800+ miles from our NYC suburban home to see relatives in Michigan at Christmas🎄If 4 airplane *tickets* were expensive, I reasoned an *entire airplane* must be hugely costly.
I found lots of good airplane info, which went into that report. But couldn't find ANYTHING about cost. I looked everywhere a kid could look in the 1970s: encyclopedias, school books, library books. Nothing. Desperate, I made up a plausible number 😲 and added it to the report.
I’ve never posted a @tiktok_us link before, but this is a rare opportunity to observe one of the most poorly understood disorders in #hematology: Gardner-Diamond syndrome. This young woman's skin lesions first appear about 40 seconds in./1 #MedTwittertiktok.com/@nancy.xoxx/vi…
The syndrome was described by Drs. Frank Gardner (1919-2013) and Louis K. Diamond (1902-1999) in Boston in 1955, in @BloodJournal. They reported 4 cases, all women, who had a peculiar form of bruising on face or extremities but had no other bleeding & normal coagulation tests./2
The key finding in Gardner-Diamond syndrome: unexplained painful bruises, most commonly on extremities or face, often during times of stress. The pathophysiology is unclear, as described below. Many patients have been dismissed by physicians as having a fictitious disorder./3
Among the many things I am #thankful for: recent progress in hematologic malignancies. When I started my career - not that long ago! - standard therapy for myeloma was melphalan & prednisone or VMP, chlorambucil for CLL, CHOP (without R) for NHL, epoetin & transfusions for MDS./1
CML was treated with Hydrea, busulfan, or interferon & Ara-C,and the big debate was transplant timing. Most patients didn't have an allo transplant donor & the age cutoff was 50-55. Karyotyping was inconsistently done even in AML/MDS; FISH was new; single gene testing was rare./2
No one knew about JAK2 mutations, let alone envisioning specific JAK2 inhibitors. There were elderly patients with polycythemia we treated with radiophosphorous. Many clinical trials were small IITs. The most "exciting" progress was in hairy cell leukemia: pentostatin & 2-CDA./3